Viewing nowUnipitoh Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

MFDS item code 201306380 · Approved 2013.03.22 · Insurance code 649506230
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps in reducing the risk of cardiovascular disease. It is particularly effective in adults aged 10 to 17 with heterozygous familial hypercholesterolemia, as well as in older adults or those with multiple risk factors such as smoking and hypertension, and patients with type 2 diabetes for the reduction of myocardial infarction and stroke risk. It also helps reduce the risk of angina, need for vascular grafting, and hospitalization due to congestive heart failure. For patients with hyperlipidemia, it improves cholesterol and triglyceride levels while serving as adjunct therapy to increase HDL cholesterol. It is safe to help manage total cholesterol and LDL cholesterol levels in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia. Overall, it effectively improves cardiovascular health and decreases the risk of related diseases.
Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL-cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only for those requiring an LDL-cholesterol reduction of 45 % or greater). This medicine is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and adjust the dose accordingly. Since the goal of treatment is to lower LDL-cholesterol, it is recommended that LDL-cholesterol levels be used when initiating treatment and evaluating response. However, if LDL-cholesterol levels are unavailable, total cholesterol levels should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL-cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine greater than 20 mg in pediatric patients). Adjust the dose appropriately according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer.
This medication may cause muscular symptoms, so if severe muscle pain or weakness occurs, or if there is a significant increase in creatine kinase levels, the medication should be discontinued immediately and a doctor should be consulted. Patients with liver function problems or active liver disease should not take this medication, and liver function tests must be conducted regularly. Women who are pregnant, may become pregnant, or are nursing should not take this medication, and women of childbearing potential should use appropriate contraception while on this medication. Children under the age of 10, patients with muscular diseases, and those with certain genetic lactose intolerance should also not take this medication. Patients with a history of alcoholism or liver disease should take this medication with caution, and those at high risk of myopathy should be closely monitored for muscular conditions. This medication can interact with certain drugs, so those taking other medications must inform their doctor or pharmacist. There is no special antidote in case of overdose, so treatment should be provided according to symptoms and regular checks of liver function and muscle enzymes should be performed. This medication should be kept out of reach of children and should be stored sealed in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This storage will help preserve the medication's effectiveness and safety for a longer period.
White round film-coated tablet
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.